Regarding chromosomal alterations, existing studies have demonstrated that in ER+ and HER2+ breast cancers, recurrent arm-level events observed in metastatic tumors, as compared to primary tumors, are predominantly clonal (21). This evidence concerns the gene ESR1 and breast carcinoma.